Oscar hopeful among first films announced for Dallas Film Festival
Movie Bonanza
Stay updated with breaking news from James Faust. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Movie Bonanza
A North County man at the center of a Panamanian murder investigation pleaded guilty in San Diego federal court Wednesday, admitting to fatally stabbing his
Dallas Love Field Launches “Lead With Love” podcast May 14, 2021 | 1 Dallas Love Field launches a new podcast on June 1 titled Lead With Love. Rather than a traditional host, it will feature a conversation between multiple voices of Dallas discussing ways that strong leadership, respect of diversity and inclusion, and celebration of local culture make a difference in the community. The show’s guests will converse and answer audience questions in a 30-minute lunchtime discussion. The first season kicks off on June 1 at 12:30 p.m. and can be watched live on Love Field’s social media o...
03.09.21 -- Incorporating Excipients Into QbD Studies For Drug Development -- An Introduction Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs. Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more! By Brian Carlin (DFE Pharma), Chris Moreton (FinnBrit Consulting), Dave Schoneker (Black Diamond Consulting), K...
01.21.21 -- Using Production And Postmarket Data To Validate FMEA Assumptions Acepodia's Dr. Sony Hsiao, CEO, and Dr. Mark Gilbert, SVP of R&D, join Business of Biotech for a discussion on the company's approach to dramatically reducing the cost of cell therapy development, manufacturing, and administration via its oNK, CAR, and ACC candidates. Listen now and subscribe so you never miss an episode. Featured Editorial By Mark Durivage, Quality Systems Compliance LLC One common issue with regulatory agencies and certification bodies regarding failure mode a...